Geoffrey M. Price - 17 Mar 2023 Form 4 Insider Report for Oak Street Health, Inc.

Role
Chief Innovation Officer, Director
Signature
/s/ Robert Guenthner, attorney-in-fact for Geoffrey Price
Issuer symbol
N/A
Transactions as of
17 Mar 2023
Net transactions value
-$1,350,689
Form type
4
Filing time
21 Mar 2023, 21:33:55 UTC
Previous filing
22 Mar 2023
Next filing
22 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OSH Common Stock, $0.001 par value Options Exercise $796,173 +37,913 +0.98% $21.00 3,912,682 17 Mar 2023 Direct F1
transaction OSH Common Stock, $0.001 par value Sale $1,350,689 -37,913 -0.97% $35.63 3,874,769 17 Mar 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OSH Employee Stock Option (Right to Buy) Options Exercise $796,173 -37,913 -2.1% $21.00 1,799,281 17 Mar 2023 Common Stock, par value $0.001 37,913 $21.00 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
F2 The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.60 to $35.68, inclusive. The Reporting Person undertakes to provide to Oak Street Health, Inc., any security holder of Oak Street Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote (2).
F3 The reported securities include the aggregate options, all of which were issued at the time of the Issuer's initial public offering, held by the Reporting Person, a portion of which remains subject to vesting.